Wall Street Experts
ver. ZuMIgo(08/25)
BioMarin Pharmaceutical Inc.
Rachunek Zysków i Strat
Przychody TTM (mln): 2 749
EBIT TTM (mln): 408
index |
0 |
1 |
2 |
3 |
4 |
5 |
6 |
7 |
8 |
9 |
10 |
11 |
12 |
13 |
14 |
15 |
16 |
17 |
18 |
19 |
20 |
21 |
22 |
23 |
24 |
25 |
Rok finansowy |
1999 |
2000 |
2001 |
2002 |
2003 |
2004 |
2005 |
2006 |
2007 |
2008 |
2009 |
2010 |
2011 |
2012 |
2013 |
2014 |
2015 |
2016 |
2017 |
2018 |
2019 |
2020 |
2021 |
2022 |
2023 |
2024 |
Przychód (mln) |
7 |
12 |
12 |
14 |
12 |
19 |
26 |
84 |
122 |
296 |
325 |
376 |
441 |
501 |
548 |
751 |
890 |
1,117 |
1,314 |
1,491 |
1,704 |
1,860 |
1,846 |
2,096 |
2,419 |
2,854 |
Przychód Δ r/r |
0.0% |
76.7% |
-5.1% |
19.0% |
-13.1% |
54.1% |
37.7% |
228.1% |
44.4% |
143.9% |
9.5% |
15.9% |
17.3% |
13.5% |
9.5% |
36.9% |
18.5% |
25.5% |
17.6% |
13.5% |
14.3% |
9.2% |
-0.8% |
13.5% |
15.4% |
18.0% |
Marża brutto |
187.4% |
153.7% |
100.0% |
100.0% |
100.0% |
78.8% |
89.8% |
89.6% |
84.9% |
82.3% |
79.7% |
81.3% |
81.0% |
81.7% |
82.5% |
82.7% |
82.9% |
81.2% |
81.6% |
78.9% |
78.9% |
71.8% |
74.5% |
76.9% |
76.1% |
79.7% |
EBIT (mln) |
-27 |
-33 |
-52 |
-79 |
-76 |
-179 |
-64 |
-25 |
-57 |
40 |
16 |
1 |
-34 |
-110 |
-156 |
-93 |
-111 |
-803 |
-15 |
-124 |
-125 |
-96 |
-60 |
58 |
158 |
484 |
EBIT Δ r/r |
0.0% |
20.0% |
57.4% |
51.8% |
-3.9% |
136.6% |
-64.2% |
-61.6% |
132.2% |
-169.4% |
-58.7% |
-96.7% |
-6329.8% |
225.2% |
41.5% |
-40.5% |
19.2% |
625.8% |
-98.2% |
740.3% |
1.6% |
-23.3% |
-37.7% |
-195.9% |
173.9% |
207.2% |
EBIT (%) |
-394.2% |
-267.7% |
-444.0% |
-566.5% |
-626.5% |
-962.2% |
-250.2% |
-29.3% |
-47.1% |
13.4% |
5.1% |
0.1% |
-7.7% |
-22.0% |
-28.4% |
-12.4% |
-12.4% |
-71.9% |
-1.1% |
-8.3% |
-7.4% |
-5.2% |
-3.3% |
2.7% |
6.5% |
17.0% |
Koszty finansowe (mln) |
0 |
0 |
0 |
-1 |
3 |
-11 |
12 |
17 |
-14 |
16 |
14 |
10 |
8 |
8 |
10 |
37 |
38 |
39 |
43 |
44 |
23 |
29 |
15 |
16 |
17 |
12 |
EBITDA (mln) |
-19 |
-18 |
-22 |
-38 |
-48 |
-35 |
-54 |
-13 |
-53 |
54 |
22 |
8 |
-32 |
-92 |
-119 |
-138 |
-287 |
-192 |
-72 |
-100 |
-22 |
-6 |
48 |
160 |
262 |
651 |
EBITDA(%) |
-276.2% |
-148.7% |
-185.1% |
-275.5% |
-394.0% |
-187.4% |
-210.9% |
-15.1% |
-43.5% |
18.3% |
6.7% |
2.1% |
-7.2% |
-18.4% |
-21.7% |
-18.3% |
-32.3% |
-17.2% |
-5.5% |
-6.7% |
-1.3% |
-0.3% |
2.6% |
7.6% |
10.8% |
22.8% |
Podatek (mln) |
1 |
4 |
20 |
10 |
-0 |
37 |
22 |
23 |
1 |
3 |
1 |
-227 |
10 |
-4 |
-0 |
9 |
17 |
-201 |
81 |
-65 |
-71 |
-901 |
-11 |
8 |
21 |
115 |
Zysk Netto (mln) |
-28 |
-37 |
-68 |
-77 |
-76 |
-187 |
-74 |
-29 |
-16 |
31 |
-0 |
206 |
-54 |
-114 |
-176 |
-134 |
-172 |
-630 |
-117 |
-77 |
-24 |
854 |
-64 |
142 |
168 |
427 |
Zysk netto Δ r/r |
0.0% |
33.1% |
80.9% |
14.6% |
-2.1% |
147.3% |
-60.4% |
-61.6% |
-44.6% |
-295.1% |
-101.6% |
-42276.0% |
-126.2% |
112.4% |
54.2% |
-24.0% |
28.2% |
266.8% |
-81.4% |
-34.0% |
-69.1% |
-3681.1% |
-107.5% |
-320.9% |
18.4% |
154.6% |
Zysk netto (%) |
-402.4% |
-303.1% |
-577.9% |
-556.5% |
-626.4% |
-1005.5% |
-289.3% |
-33.9% |
-13.0% |
10.4% |
-0.2% |
54.7% |
-12.2% |
-22.8% |
-32.2% |
-17.8% |
-19.3% |
-56.4% |
-8.9% |
-5.2% |
-1.4% |
45.9% |
-3.5% |
6.8% |
6.9% |
15.0% |
EPS |
-0.94 |
-1.04 |
-1.65 |
-1.45 |
-1.22 |
-2.91 |
-1.08 |
-0.34 |
-0.16 |
0.31 |
-0.0049 |
1.99 |
-0.48 |
-0.95 |
-1.28 |
-0.92 |
-1.07 |
-3.8 |
-0.67 |
-0.44 |
-0.13 |
4.75 |
-0.35 |
0.76 |
0.89 |
2.13 |
EPS (rozwodnione) |
-0.94 |
-1.04 |
-1.65 |
-1.45 |
-1.22 |
-2.91 |
-1.08 |
-0.34 |
-0.16 |
0.29 |
-0.0049 |
1.73 |
-0.48 |
-0.95 |
-1.28 |
-0.92 |
-1.07 |
-3.79 |
-0.67 |
-0.44 |
-0.13 |
4.53 |
-0.35 |
0.75 |
0.88 |
2.06 |
Ilośc akcji (mln) |
30 |
36 |
41 |
53 |
62 |
64 |
69 |
85 |
96 |
99 |
100 |
103 |
112 |
120 |
138 |
146 |
160 |
166 |
174 |
177 |
179 |
181 |
183 |
185 |
188 |
190 |
Ważona ilośc akcji (mln) |
30 |
36 |
41 |
53 |
62 |
64 |
69 |
85 |
96 |
104 |
100 |
126 |
112 |
120 |
138 |
146 |
160 |
166 |
174 |
177 |
179 |
192 |
183 |
189 |
192 |
197 |
Waluta |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |